Shackelford et al v. Eli Lilly and Company et al

Filing 91

JUDGMENT: (1) Judgment is entered in favor of Eli Lilly and Company; aaiPharma, Inc.; aaiPharma LLC; AAI Development Services, Inc.; NeoSan Pharmaceuticals Inc.; Xanodyne Pharmaceuticals, Inc.; Qualitest Pharmaceuticals, Inc.; Vintage Pharmaceut icals, Inc.; Propst Distribution, Inc.; Brenn Distribution, Inc.; Brenn Manufacturing, Inc.; Vintage Pharmaceuticals, LLC; Generics International (US), Inc.; Generics Bidco I, LLC; Generics Bidco II, LLC; Generics International (US PARENT), Inc.; E ndo Pharmaceuticals, Inc.; Endo Pharmaceuticals Holdings, Inc.; Covidien PLC; Covidien Inc.; Mallinckrodt, Inc.; Teva Biopharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals, Inc.; Mylan, Inc.; and Watson Pharmaceuticals, I nc. with respect to all claims asserted herein. (2) This action is DISMISSED and STRICKEN from the Court's docket. (3) This is a FINAL and APPEALABLE Judgment and there is no just cause for delay. Signed by Judge Danny C. Reeves on 9/5/2012. Associated Cases: 2:11-md-02226-DCR, 2:11-cv-00357-DCR(CBD)cc: COR, Clerk JPMDL

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF KENTUCKY
NORTHERN DIVISION
(at Covington)
IN RE: DARVOCET, DARVON AND
PROPOXYPHENE PRODUCTS
LIABILITY LITIGATION

)
)
)
)
)
Shackelford, et al., v. Eli Lilly & Co., et al., )
)
)
)
)

Master File No. 2: 11-md-2226-DCR
MDL Docket No. 2226
Civil Action No. 2: 11-357-DCR

JUDGMENT

*** *** *** ***
In accordance with the Court’s Order Granting Defendant Xanodyne Pharmaceuticals,
Inc.’s Motion to Dismiss and Motion for Judgment on the Pleadings in 14 Cases [MDL Record
No. 1791], Order dismissing remaining Generic Defendants [MDL Record No. 1973],
Memorandum Opinion and Order Regarding AAIPharma, LLC’s AAIPharma, Inc.’s AAIPharma
Development Services, Inc.’s, and NeoSan Pharmaceutical, Inc.’s Motion to Dismiss [MDL
Record No. 2150], and Memorandum Opinion and Order Granting Defendant Eli Lilly and
Company’s Third Master Motion for Judgment on the Pleadings in Twelve Cases [MDL Record
No. 2184], and pursuant to Rule 58 of the Federal Rules of Civil Procedure, it is hereby
ORDERED and ADJUDGED as follows:
(1)

Judgment is entered in favor of Eli Lilly and Company; aaiPharma, Inc.;

aaiPharma LLC; AAI Development Services, Inc.; NeoSan Pharmaceuticals Inc.; Xanodyne
Pharmaceuticals, Inc.; Qualitest Pharmaceuticals, Inc.; Vintage Pharmaceuticals, Inc.; Propst

-1-

Distribution, Inc.; Brenn Distribution, Inc.; Brenn Manufacturing, Inc.; Vintage Pharmaceuticals,
LLC; Generics International (US), Inc.; Generics Bidco I, LLC; Generics Bidco II, LLC;
Generics International (US PARENT), Inc.; Endo Pharmaceuticals, Inc.; Endo Pharmaceuticals
Holdings, Inc.; Covidien PLC; Covidien Inc.; Mallinckrodt, Inc.; Teva Biopharmaceuticals, Inc.;
Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals, Inc.; Mylan, Inc.; and Watson
Pharmaceuticals, Inc. with respect to all claims asserted herein.
(2)

This action is DISMISSED and STRICKEN from the Court’s docket.

(3)

This is a FINAL and APPEALABLE Judgment and there is no just cause for

delay.
This 5th day of September, 2012.

-2-